Vanguard Fiduciary Trust
ELTX icon

Vanguard Fiduciary Trust’s Elicio Therapeutics ELTX Stock Holding History

Vanguard Fiduciary Trust’s Portfolio ELTX Stock Details ELTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$344K Buy
88,062
+18,873
+27% +$189K ﹤0.01% 3399
2026
Q1 		$740K Buy
+69,189
New +$668K ﹤0.01% 3050

Other funds holding ELTX

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Fiduciary Trust's ELTX Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Elicio Therapeutics (ELTX) stake by 27% in Q2 2026, buying an estimated $189K and bringing the position to 88,062 shares worth $344K. The position accounts for ﹤0.01% of the portfolio, ranked #3399.

Vanguard Fiduciary Trust first reported a position in ELTX in Q1 2026 and has held it in 2 quarters since. The position peaked at $740K in Q1 2026. 46 funds tracked by Wall St. Rank hold ELTX as of Q2 2026.

  • Vanguard Fiduciary Trust held 88,062 shares of Elicio Therapeutics worth $344K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 18,873 Elicio Therapeutics shares in Q2 2026, an estimated $189K.
  • Elicio Therapeutics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3399 holding.
  • Vanguard Fiduciary Trust first reported a position in Elicio Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Elicio Therapeutics position peaked at $740K in Q1 2026.
  • 46 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.